Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720261 | SCV000527497 | likely benign | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000653365 | SCV000775244 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436300 | SCV002750628 | likely benign | Inborn genetic diseases | 2018-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |